Cryptococcus extracellular vesicles properties and their use as vaccine platforms

Area of Science:

• Mycology
• Microbiology
• Immunology
• Structural Biology

Background:

• Extracellular vesicle (EV) research is emerging in mycology, with limited understanding of fungal EVs.
• Pathogenic fungi like Cryptococcus are significant human pathogens, necessitating novel therapeutic strategies.

Purpose of the Study:

• To structurally and compositionally characterize extracellular vesicles (EVs) from pathogenic fungal species: Cryptococcus neoformans, C. deneoformans, and C. deuterogattii.
• To propose a new model for cryptococcal EV structure and analyze their protein cargo.
• To evaluate the vaccine potential of Cryptococcus EVs.

Main Methods:

• Cryogenic electron microscopy (cryo-EM) and cryogenic electron tomography (cryo-ET) for high-resolution structural analysis.
• Proteomics to identify protein composition of EVs.
• Flow cytometry for characterizing EV populations.
• Immunization studies in mice using acapsular Cryptococcus EVs.

Main Results:

• A novel structural model for fungal EVs was proposed: a lipid bilayer covered by mannoprotein fibrils and an outer layer of capsule polysaccharide.
• Approximately 10% of the EV population lacked fibrillar decoration, indicating EV diversity.
• The typical Cryptococcus EV proteome was characterized, including membrane-bound proteins like Tsh.
• EVs from an acapsular Cryptococcus neoformans mutant elicited a strong antibody response and significantly prolonged survival in infected mice.

Conclusions:

• Cryptococcus EVs possess a unique structure with potential as a vaccine candidate against fungal infections.
• The characterized EV proteome and structure provide a foundation for further research into fungal EVs.
• EV-based vaccines could offer a promising strategy for combating Cryptococcus infections.